Related Experiment Videos

Regulation of Smad signaling by protein kinase C

I Yakymovych1, P Ten Dijke, C H Heldin

  • 1Ludwig Institute for Cancer Research, Box 595, Uppsala, Sweden.

Insights

Protein kinase C (PKC) directly phosphorylates Smad3, inhibiting its DNA binding and TGF-b-mediated growth suppression and apoptosis. This reveals a key mechanism in cell signaling and cancer development.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Cancer Research

Background:

  • Cross-talk between TGF-b and tyrosine kinase receptor pathways influences cell growth, differentiation, and apoptosis.
  • Protein kinase C (PKC) is activated downstream of tyrosine kinase receptors and plays a role in cell signaling.

Purpose of the Study:

  • To elucidate the mechanism by which Smad-dependent TGF-b signaling is modulated by PKC.
  • To investigate the role of PKC-mediated Smad phosphorylation in cellular responses to growth factors and tumor promoters.

Main Methods:

  • Investigated the direct interaction and phosphorylation of Smad proteins by PKC.
  • Assessed the effect of PKC phosphorylation on Smad3 DNA-binding ability and transcriptional activity.
  • Examined the impact of modulating PKC regulation of Smad function on cell transformation and apoptosis.

Main Results:

  • PKC directly phosphorylates receptor-regulated Smad proteins, including Smad3.
  • PKC-dependent phosphorylation of Smad3 abrogates its direct DNA-binding capacity, impairing TGF-b-mediated transcription.
  • Interference with PKC regulation of Smad3 enhanced cell sensitivity to PMA-induced transformation.
  • PKC-dependent Smad3 phosphorylation is crucial for PMA-induced inactivation of TGF-b-stimulated apoptosis.

Conclusions:

  • PKC-dependent phosphorylation of Smad3 down-regulates the growth inhibitory and apoptotic effects of TGF-b.
  • This pathway represents a critical regulatory mechanism linking tyrosine kinase receptor signaling to TGF-b pathway output.
  • Targeting the PKC-Smad3 interaction may offer therapeutic strategies for cancers involving dysregulated TGF-b signaling.

Related Concept Videos